Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever

Virology Journal

Volumn 7, Issue , 2010, Pages

  Gowen, Brian B ^a   Julander, Justin G ^a   London, Nyall R ^b   Wong, Min Hui ^a   Larson, Deanna ^a   Morrey, John D ^a   Li, Dean Y ^b   Bray, Mike ^c  

^a UTAH STATE UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHEMOKINE; CYTOKINE; EVANS BLUE; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE STORM; DISEASE SEVERITY; HAMSTER; HEMATOCRIT; HEMORRHAGIC FEVER; LEUKOCYTE COUNT; NONHUMAN; PICHINDE ARENAVIRUS; VIRAL HEMORRHAGIC FEVER; ANIMAL; BLOOD; CAPILLARY PERMEABILITY; DISEASE MODEL; FEMALE; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SYRIAN HAMSTER; VIRUS HEMORRHAGIC FEVER;

ANIMALIA; BACTERIA (MICROORGANISMS); CRICETINAE; PICHINDE VIRUS; RNA VIRUSES; RODENTIA;

ANIMALS; CAPILLARY PERMEABILITY; CRICETINAE; CYTOKINES; DISEASE MODELS, ANIMAL; EVANS BLUE; FEMALE; HEMATOCRIT; HEMORRHAGIC FEVERS, VIRAL; MESOCRICETUS; PICHINDE VIRUS; SERUM ALBUMIN;

EID: 77956570798     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-240     Document Type: Article

References (25)

1. Pathogenesis of viral hemorrhagic fever. M Bray, Curr Opin Immunol 2005 17 399 403 10.1016/j.coi.2005.05.001 15955687
2. Viral haemorrhagic fever and vascular alterations. P Aleksandrowicz K Wolf D Falzarano H Feldmann J Seebach H Schnittler, Hamostaseologie 2008 28 77 84 18278167
3. Dengue and dengue hemorrhagic fever. DJ Gubler, Clin Microbiol Rev 1998 11 480 496 9665979
4. Biochemical alterations as markers of dengue hemorrhagic fever. LA Villar-Centeno FA Diaz-Quijano RA Martinez-Vega, Am J Trop Med Hyg 2008 78 370 374 18337328
5. Murine model for dengue virus-induced lethal disease with increased vascular permeability. S Shresta KL Sharar DM Prigozhin PR Beatty E Harris, J Virol 2006 80 10208 10217 10.1128/JVI.00062-06 17005698
6. CLEC5A is critical for dengue-virus-induced lethal disease. ST Chen YL Lin MT Huang MF Wu SC Cheng HY Lei CK Lee TW Chiou CH Wong SL Hsieh, Nature 2008 453 672 676 10.1038/nature07013 18496526
7. Clinical Studies of the Blood Volume. I. Clinical Application of a Method Employing the Azo Dye "Evans Blue" and the Spectrophotometer. JG Gibson WA Evans, J Clin Invest 1937 16 301 316 10.1172/JCI100859 16694480
8. A method for determination of plasma and blood volume. LG Rowntree JT Geraghty, Arch Intern Med 1915 16 547 557
9. Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia. LF Thompson HK Eltzschig JC Ibla CJ Van De Wiele R Resta JC Morote-Garcia SP Colgan, J Exp Med 2004 200 1395 1405 10.1084/jem.20040915 15583013
10. Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses. BB Gowen MR Holbrook, Antiviral Res 2008 78 79 90 10.1016/j.antiviral.2007.10.002 18036672
11. Comparison of the lateral tail vein and the retro-orbital venous sinus as routes of intravenous drug delivery in a transgenic mouse model. CD Steel AL Stephens SM Hahto SJ Singletary RP Ciavarra, Lab Anim (NY) 2008 37 26 32 10.1038/laban0108-26 18094699
12. Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin. BB Gowen DF Smee MH Wong JO Hall KH Jung KW Bailey JR Stevens Y Furuta JD Morrey, PLoS One 2008 3 3725 10.1371/journal.pone.0003725 19008960
13. Clinical laboratory, virologic, and pathologic changes in hamsters experimentally infected with Pirital virus (Arenaviridae): a rodent model of Lassa fever. E Sbrana RI Mateo SY Xiao VL Popov PC Newman RB Tesh, Am J Trop Med Hyg 2006 74 1096 1102 16760527
14. Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model. JG Julander JD Morrey LM Blatt K Shafer RW Sidwell, Antiviral Res 2007 73 140 146 10.1016/j.antiviral.2006.08.008 17049380
15. Experimental yellow fever virus infection in the golden hamster (Mesocricetus auratus) III. Clinical laboratory values. E Sbrana SY Xiao VL Popov PC Newman RB Tesh, Am J Trop Med Hyg 2006 74 1084 1089 16760525
16. Lassa fever. Effective therapy with ribavirin. JB McCormick IJ King PA Webb CL Scribner RB Craven KM Johnson LH Elliott R Belmont-Williams, N Engl J Med 1986 314 20 26 10.1056/NEJM198601023140104 3940312
17. Activity of T-1106 in a hamster model of yellow Fever virus infection. JG Julander Y Furuta K Shafer RW Sidwell, Antimicrob Agents Chemother 2007 51 1962 1966 10.1128/AAC.01494-06 17420215
18. Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies. RB Tesh H Guzman AP da Rosa PF Vasconcelos LB Dias JE Bunnell H Zhang SY Xiao, J Infect Dis 2001 183 1431 1436 10.1086/320199 11319679
19. Endogenous endothelial cell signaling systems maintain vascular stability. NR London KJ Whitehead DY Li, Angiogenesis 2009 12 149 158 10.1007/s10456-009-9130-z 19172407
20. Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV). J Balzarini H Mitsuya E De Clercq S Broder, Int J Cancer 1986 37 451 457 10.1002/ijc.2910370318 2419266
21. Effect of Evans blue and trypan blue on syncytia formation and infectivity of human immunodeficiency virus type I and type II in vitro. R Pal S Mumbauer G Hoke R Larocca C Myers MG Sarngadharan CA Stein, AIDS Res Hum Retroviruses 1991 7 537 543 10.1089/aid.1991.7.537 1718343
22. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. D Schols R Pauwels J Desmyter E De Clercq, Virology 1990 175 556 561 10.1016/0042-6822(90)90440-3 1691563
23. Exotic emerging viral diseases: progress and challenges. TW Geisbert PB Jahrling, Nat Med 2004 10 110 121 10.1038/nm1142 15577929
24. Viral hemorrhagic fever - a vascular disease? HJ Schnittler H Feldmann, Thromb Haemost 2003 89 967 972 12783108
25. Targeting Robo4-dependent slit signaling to survive the cytokine storm in sepsis and influenza. NR London W Zhu FA Bozza MC Smith DM Greif LK Sorensen L Chen Y Kaminoh AC Chan SF Passi,, et al. Sci Transl Med 2010 2 23ra19 20375003